Upgrade to SI Premium - Free Trial

Guardant Health (GH) PT Raised to $60 at Leerink Partners

November 7, 2024 5:56 AM
Leerink Partners analyst Puneet Souda raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $50.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles